Norman XIANGLONG KONG - Publications

Affiliations: 
State University of New York, Buffalo, Buffalo, NY, United States 
Area:
Organic Chemistry

3/8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2002 Davies HM, Ren P, Kong NX, Sexton T, Childers SR. Synthesis of iodinated 3beta-aryltropanes with selective binding to either the dopamine or serotonin transporters. Bioorganic & Medicinal Chemistry Letters. 12: 845-7. PMID 11958976 DOI: 10.1016/S0960-894X(02)00048-3  0.489
2001 Davies HML, Xiang B, Kong N, Stafford DG. Catalytic asymmetric synthesis of highly functionalized cyclopentenes by a [3 + 2] cycloaddition [20] Journal of the American Chemical Society. 123: 7461-7462. PMID 11472193 DOI: 10.1021/Ja0160546  0.305
2001 Davies HM, Ren P, Kong N, Sexton T, Childers SR. Synthesis and monoamine transporter affinity of 3beta-(4-(2-pyrrolyl)phenyl)-8-azabicycl. Bioorganic & Medicinal Chemistry Letters. 11: 487-9. PMID 11229754 DOI: 10.1016/S0960-894X(00)00701-0  0.483
Low-probability matches (unlikely to be authored by this person)
1998 Davies HML, Kong N, Churchill MR. Asymmetric Synthesis of Cyclopentenes by [3 + 2] Annulations between Vinylcarbenoids and Vinyl Ethers The Journal of Organic Chemistry. 63: 6586-6589. DOI: 10.1021/Jo980738N  0.287
1997 Davies HML, Kong N. Synthesis and evaluation of a novel dirhodium tetraprolinate catalyst containing bridging prolinate ligands Tetrahedron Letters. 38: 4203-4206. DOI: 10.1016/S0040-4039(97)00897-6  0.275
2013 Donnell AF, Michoud C, Rupert KC, Han X, Aguilar D, Frank KB, Fretland AJ, Gao L, Goggin B, Hogg JH, Hong K, Janson CA, Kester RF, Kong N, Le K, et al. Benzazepinones and benzoxazepinones as antagonists of inhibitor of apoptosis proteins (IAPs) selective for the second baculovirus IAP repeat (BIR2) domain. Journal of Medicinal Chemistry. 56: 7772-87. PMID 24083782 DOI: 10.1021/jm400731m  0.205
2004 Vassilev LT, Vu BT, Graves B, Carvajal D, Podlaski F, Filipovic Z, Kong N, Kammlott U, Lukacs C, Klein C, Fotouhi N, Liu EA. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science (New York, N.Y.). 303: 844-8. PMID 14704432 DOI: 10.1126/science.1092472  0.138
2009 Daouti S, Wang H, Li WH, Higgins B, Kolinsky K, Packman K, Specian A, Kong N, Huby N, Wen Y, Xiang Q, Podlaski FJ, He Y, Fotouhi N, Heimbrook D, et al. Characterization of a novel mitogen-activated protein kinase kinase 1/2 inhibitor with a unique mechanism of action for cancer therapy. Cancer Research. 69: 1924-32. PMID 19244124 DOI: 10.1158/0008-5472.CAN-08-2627  0.047
Hide low-probability matches.